LUTRELEF subst sèche 3.2 mg c solv flac

7680473660388 CH-47366 H01CA01 07.03.1.
LUTRELEF subst sèche 3.2 mg c solv flac
LUTRELEF subst sèche 3.2 mg c solv flac
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
4736602
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio cryodesiccata: gonadorelini acetas 3.2 mg corresp. gonadorelinum 2.91 mg, mannitolum acidum hydrochloridum, pro vitro. Solvens: natrii chloridum corresp. natrium 35.4 mg, acidum hydrochloridum, aqua ad iniectabile 10 ml.

Articles (1)

Lutrelef 3,2 mg, Injektionspräparat
Injektionspräparat
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
28/07/2022
Professional SmPC
Français
28/07/2022
Professional SmPC
Italien
28/07/2022

Detailed composition

Substance Quantity Type Category
natrii chloridum
- Substance HNIDK
gonadorelini acetas
3.2 MG Substance WIZUS
natrium
35.4 MG Substance HBESI
gonadorelinum
2.91 MG Substance Wirkstoff (Principe actif)
acidum hydrochloridum
- Substance HNIDK
mannitolum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
10.0 ML Substance HNIDK

Authorization holder

Ferring AG

6340 Baar

Authorization information

Swissmedic authorization number
47366
Drug name
Lutrelef, Injektionspräparat
Galenic form
PULMJ
ATC Code
H01CA01
Authorization status
Z
Dispensation category
B
First authorization
04/08/1986
Authorization expiration date
31/12/9999
IT number
07.03.1.
Domain
Human medicine
Field of application
Hypothalamische Amenorrhoe, zentraler Hypogonadismus beim Mann

Packaging details

Description (FR)
LUTRELEF subst sèche 3.2 mg c solv flac
Description (DE)
LUTRELEF Trockensub 3.2 mg c Solv Durchstf
Market launch
04/08/1986
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data